Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bio-Techne (TECH)
NASDAQ:TECH
Holding TECH?
Track your performance easily
TECH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$51.79 - $85.57
Previous Close$74.76
Volume931.64K
Average Volume (3M)986.81K
Market Cap
$11.86B
Enterprise Value$12.13B
Total Cash (Recent Filing)$152.86M
Total Debt (Recent Filing)$419.54M
Price to Earnings (P/E)71.5
Beta1.20
Next Earnings
Oct 29, 2024EPS Estimate
$0.38Last Dividend Ex-Date
Aug 19, 2024Dividend Yield0.43%
Share Statistics
EPS (TTM)1.04
Shares Outstanding158,600,408
10 Day Avg. Volume767,207
30 Day Avg. Volume986,810
Standard Deviation0.10
R-Squared0.40
Alpha-0.00271
Financial Highlights & Ratios
Price to Book (P/B)5.73
Price to Sales (P/S)10.22
Price to Cash Flow (P/CF)39.20
P/FCF Ratio51.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue10.46
Enterprise Value/Gross Profit15.75
Enterprise Value/Ebitda39.04
Forecast
1Y Price Target
$81.13Price Target Upside8.52% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Bio-Techne News
PremiumPress Releases
BIO-TECHNE DECLARES DIVIDEND
Bulls Say, Bears Say
Bulls Say
Financial PerformanceBio-Techne delivered revenue and EPS in line with consensus, driven by strong performance in Diagnostics and Genomics.
Growth PotentialManagement highlighted positive indicators such as growth in cell and gene therapy customers and a continued backlog growth in spatial, positioning the company for future success.
Market StrategyBio-Techne's new high-throughput Simple Western platform, Leo, is set to launch, targeting an automated western blot market that is still under-penetrated.
Bears Say
Adjusted MarginsAdjusted operating margin percentage fell approximately 360 basis points year over year, to 33.5%, driven by unfavorable volume leverage and mix.
Operating MarginsDxG operating margins declined to 12.5% from 18.5%, primarily driven by Lunaphore dilution.
Stock PerformanceBio-Techne stock gave back year-to-date gains, down 9.5% compared to XBI's 2.2% drop.
---
Ownership Overview
2.28% Insiders
44.40% Mutual Funds
49.78% Other Institutional Investors
3.54% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TECH FAQ
What was Bio-Techne’s price range in the past 12 months?
Bio-Techne lowest stock price was $51.79 and its highest was $85.57 in the past 12 months.
What is Bio-Techne’s market cap?
Currently, no data Available
When is Bio-Techne’s upcoming earnings report date?
Bio-Techne’s upcoming earnings report date is Oct 29, 2024 which is in 39 days.
How were Bio-Techne’s earnings last quarter?
Bio-Techne released its earnings results on Aug 07, 2024. The company reported $0.49 earnings per share for the quarter, missing the consensus estimate of $0.495 by -$0.005.
Is Bio-Techne overvalued?
According to Wall Street analysts Bio-Techne’s price is currently Undervalued.
Does Bio-Techne pay dividends?
Bio-Techne pays a Quarterly dividend of $0.08 which represents an annual dividend yield of 0.43%. See more information on Bio-Techne dividends here
What is Bio-Techne’s EPS estimate?
Bio-Techne’s EPS estimate is $0.38.
How many shares outstanding does Bio-Techne have?
Bio-Techne has 158,645,500 shares outstanding.
What happened to Bio-Techne’s price movement after its last earnings report?
Bio-Techne reported an EPS of $0.49 in its last earnings report, missing expectations of $0.495. Following the earnings report the stock price went down -9.523%.
Which hedge fund is a major shareholder of Bio-Techne?
Among the largest hedge funds holding Bio-Techne’s share is Mairs & Power Inc. It holds Bio-Techne’s shares valued at 196M.
---
Bio-Techne Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$81.13 (8.52% Upside)
$81.13 (8.52% Upside)
Blogger Sentiment
Bullish
TECH Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 149.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
3.48%
12-Months-Change
Fundamentals
Return on Equity
8.33%
Trailing 12-Months
Asset Growth
2.91%
Trailing 12-Months
Company Description
Bio-Techne
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Biotechnology, Protein Platforms, Diagnostics, and Corporate. The Biotechnology segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and related reagents, as well as in situ hybridization, media and other cell culture products and reagents to the biotechnology research community. The Protein Platforms segment develops, manufactures, and sells tools to simplify protein analysis. The Diagnostics segment includes blood chemistry and blood gas quality controls, hematology instrument controls, diagnostic immunoassays, and other bulk and custom reagents for the in vitro diagnostic market worldwide. The company was founded on 1976 and is headquartered in Minneapolis, MN.
---
TECH Earnings Call
Q4 2024
0:00 / 0:00
---
TECH Net revenue Breakdown
74.40% Protein Sciences
25.74% Diagnostics and Genomics
---
TECH Stock 12 Month Forecast
Average Price Target
$81.13
▲(8.52% Upside)
Technical Analysis
Best Analysts Covering TECH
1 Year
1 Year Success Rate
20/32 ratings generated profit
1 Year Average Return
+14.39%
reiterated a buy rating 22 days ago
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +14.39% per trade.
---